Last week, European regulators recommended a similar warning for AstraZeneca's COVID-19 vaccine, which is based on a similar technology as Johnson & Johnson's one-dose shot.
The warning is another setback for the J&J vaccine, which was supposed to be an important tool for vaccinating in hard-to-reach areas and among those hesitant to be vaccinated because it requires only one shot and has less stringent storage requirements than the Pfizer or Moderna vaccines.
¿Fue útil esta página ¡Danos un pulgar hacia arriba!
+1Útil ( 48 )
Inútil ( 7 )
Entregar
¡Gracias por tus comentarios!
